Mary Elizabeth Poston, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 2708 Jefferson Dr Ste A, Liberty, TX 77575 Phone: 936-334-8800 Fax: 936-334-8801 |
Ms. Shelly Margaret States, P.A Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1353 N Travis St, Liberty, TX 77575 Phone: 832-397-9283 |
Heather Reed, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1353 N Travis St, Liberty, TX 77575 Phone: 936-336-9175 Fax: 936-336-8581 |
Edwin Allen Morgan Iii, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1353 N Travis St, Liberty, TX 77575 Phone: 936-697-6959 |
Ms. Maria Guadalupe Sanchez, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2708 Jefferson Dr Ste A, Liberty, TX 77575 Phone: 936-334-8800 Fax: 936-334-8801 |
Samantha Kaye Spata, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1400 N Travis St, Liberty, TX 77575 Phone: 936-334-1185 |
News Archive
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a process that controls the amount of fat that cells store for use as a back-up energy source.
The court could upend the national health law if the justices decide the mandate is unconstitutional. Yet, planning for full implementation of the law in Massachusetts is moving "full steam ahead," said Glen Shor, executive director of the Massachusetts Health Connector, the agency that runs the state's health insurance exchange. ... Lawmakers in Colorado, for example, created the infrastructure needed to set up the state's health insurance exchange earlier this year.
Pediatric cancer specialists at The Children's Hospital at Montefiore (CHAM) are investigating a new type of inhalation chemotherapy with the potential to treat children with a deadly bone cancer that has spread to their lungs.
A new study of patients who underwent curative surgical removal of a pancreatic ductal adenocarcinoma showed that two of the nine preoperative factors analyzed were strongly predictive of poor prognosis regardless of the tumor stage.
Promethera Biosciences, a Belgian biotechnology company developing Promethera(R) HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announced that it has successfully treated a patient with liver progenitor cells enrolled in its Phase I/II trial.
› Verified 6 days ago